KCT0002873已完成未知
Comparison of cilostazol-based triple antiplatelet therapy versus dual antiplatelet therapy for outcomes of below-the knee endovascular intervention in patients with critical limb ischemia (TAP CLI study)
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 175
研究概览
简要总结
.
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 84(Year)（—）
- 性别
- All
入选标准
- •Patients = 19 years old
- •- Patients with critical limb ischemia (Rutherford 4 & 5)
- •- Successful below-the knee endovascular intervention.
排除标准
- •- Major bleeding event within recent 3 months or high risk of major bleeding
- •- Patients requiring anticoagulation
- •- Allergic reactions to antiplatelet drugs
- •- Acute limb ischemia
- •- Severe hepatic dysfunction (3 times GOT/GPT normal reference values)
- •- Pregnant women or women with potential childbearing
- •- Life expectancy < 1 year due to comorbidity
- •- Previous amputations in the target limb
研究者
相似试验
Unknown
4 期
Comparison of Cilostazol-based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy for Outcomes of below-the Knee Endovascular Intervention in Patients With Critical Limb Ischemia (TAP CLI Study)Critical Limb IschemiaNCT02829151Yonsei University390
已完成
4 期
Triple Versus Dual Antiplatelet Therapy in Patients Undergoing Coronary Stent ImplantationAcute Coronary SyndromeNCT00404716Shenyang Northern Hospital
已完成
4 期
The Efficacy of CILostazol ON Ischemic Complications After DES ImplantationCoronary Artery DiseaseNCT00776828Seoul National University Hospital960
已完成
4 期
Diabetic Artery Obstruction: is it Possible to Reduce Ischemic Events With Cilostazol?Ischemic StrokePeripheral Artery DiseaseDiabetes Mellitus, Type 2NCT02983214University of Ioannina826
已完成
4 期
Triple Versus Dual Antiplatelet Therapy After ABT578-Eluting StentCoronary Artery DiseaseNCT00589927CardioVascular Research Foundation, Korea486